Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 20;20(1):20221040.
doi: 10.1515/biol-2022-1040. eCollection 2025.

Effects of tiered cardiac rehabilitation on CRP, TNF-α, and physical endurance in older adults with coronary heart disease

Affiliations

Effects of tiered cardiac rehabilitation on CRP, TNF-α, and physical endurance in older adults with coronary heart disease

Cong Luo et al. Open Life Sci. .

Abstract

Coronary heart disease (CHD) is a highly prevalent disease in the elderly population, with atherosclerosis as its pathology, which can also be viewed as a chronic inflammatory response of the organism. Regular moderate-intensity exercise can direct the immune response toward an anti-inflammatory state, which is beneficial for improving the health and exercise tolerance. In cardiac rehabilitation, attention to the management of inflammatory factors as well as the improvement of exercise endurance is beneficial for the rehabilitation of elderly patients with coronary artery disease. This study investigates the impact of tiered cardiac rehabilitation programs on levels of C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), and the capacity for physical exertion in older CHD patients. From March 2020 to April 2022, 94 elderly patients with CHD visiting our institution were recruited and randomly allocated into either a control group or an observation group, each comprising 47 participants. The standard care group participated in traditional rehabilitation exercises, whereas the experimental group received customized, tiered, cardiac rehabilitation interventions. We assessed the variations in CRP and tumor necrosis factor alpha (TNF-α) levels, along with exercise capacity, before and after treatment in both groups. The result shows that significant reductions in CRP and TNF-α levels were seen in the experimental group after 4 and 12 weeks, compared to the standard care group. Analysis showed clear trends in CRP and TNF-α changes over the interventions, with the experimental group showing better results. CRP levels decreased consistently, while TNF-α levels stayed stable. The experimental group also showed improvements in physical endurance measures compared to the control group. Interleukin 6 (IL-6) and fibrinogen (Fib) in the observation group decreased compared with the control group (P < 0.01). After 12 weeks of treatment, CRP and TNF-α showed significant negative correlation with exercise endurance index - 6 min walking test (6 MWT), anaerobic threshold (AT), maximum oxygen consumption (VO2max), and exercise duration (ED); significant positive correlation between cardiac rehabilitation grade and exercise endurance index (6 MWT, AT, VO2max and ED); and both groups experienced cardiovascular adverse events and exercise muscle injury. The analysis shows that the graded nursing of cardiac rehabilitation can effectively reduce the levels of CRP, TNF-α, IL-6, and Fib in elderly patients with CHD and significantly improve the exercise endurance of patients with good safety.

Keywords: CRP; coronary heart disease; elderly; exercise tolerance; stratified cardiac rehabilitation.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Authors state no conflict of interest.

Figures

None
Graphical abstract
Figure 1
Figure 1
Changes in CRP and TNF-α levels for the two patient groups. Note: In the figure blue indicates the control group, red indicates the observation group, ns is not statistically significant, ** indicates P < 0.001, T0 indicates before treatment, T4w is at 4 weeks of treatment, and T12w is at 12 weeks of treatment. (a) Change in CRP levels and (b) change in TNF-α levels.
Figure 2
Figure 2
Changes in IL-6 and Fib levels between the two groups. Note: In the figure, blue indicates the control group, red indicates the observation group, ns means not statistically significant, ns indicates P > 0.05, * indicates P < 0.01, ** indicates P < 0.001, T0 is before treatment, and T12w is for 12 weeks of treatment. (a) Changes in IL-6 levels and (b) Changes in Fib levels.
Figure 3
Figure 3
Comparison of changes in indicators related to exercise tolerance between the two groups. Note: In the figure, blue indicates the control group, red indicates the observation group, ns indicates that the comparison between groups is not statistically significant, ns indicates P > 0.05, * indicates P < 0.01, ** indicates P < 0.001, and straight lines and dotted lines indicate the change trend among the three time points of the two groups. (a) 6MWT, (b) AT, (c) VO2max, and (d) ED.

References

    1. Hossne NA, Jr, Dallan L, Lisboa L, Murad H, Gomes WJ. Official scientific statement from the brazilian society of cardiovascular surgery - The 2021 ACC/AHA/SCAI Guideline for coronary artery revascularization and the 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for chronic coronary disease. Braz J Cardiovasc Surg. 2024;39(2):e20240990. - PMC - PubMed
    1. Safiri S, Karamzad N, Singh K, Carson-Chahhoud K, Adams C, Nejadghaderi SA, et al. Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990-2019. Eur J Prev Cardiol. 2022;29(2):420–31. - PubMed
    1. Svinin GE, Kutsenko VA, Shalnova SA, Yarovaya EB, Imaeva AE, Balanova YA, et al. Validation of SCORE2 on a sample from the Russian population and adaptation for the very high cardiovascular disease risk region. PLoS One. 2024;19(4):e0300974. - PMC - PubMed
    1. Luo C, Li L, Hou L, Shi F. 2020 PgftCCHaDR. Interpretation of report on cardiovascular health and diseases in China 2020. Chin J Cardiovasc Med. 2021;26(3):209–18.
    1. Kurl S, Jae SY, Voutilainen A, Laukkanen JA. The combined effect of blood pressure and C-reactive protein with the risk of mortality from coronary heart and cardiovascular diseases. Nutr Metab Cardiovasc Dis. 2021;31(7):2051–7. - PubMed

LinkOut - more resources